Clinical Trial Update: Safety, Blood Levels and Effects of GW642444 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety, pharmacokinetics (blood levels), and effects of GW642444 in chronic obstructive pulmonary disease. The study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GW642444 (GW642444)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED